Research Highlights

Research Highlights
Current Location:Home > Research Highlights > Research Highlights
  • Adv. Mater. 2017, 29, 1603997

    X-Ray computed tomography (CT) owing to its high resolution, deep tissue penetration, low cost, and wide availability has become one of the clinically most use

    More+
  • Small 2017, 13, 1601997.

    Cyclo(Arg-Gly-Asp) peptide (cRGD) decorated disulfide (SS) containing poly(vinyl alcohol) nanogels (cRGD-SS-NGs) with an average diameter of 142 nm prepared by

    More+
  • J. Control. Release 2017, 250, 9-19.

    Slow drug release at the tumor tissue and poor tumor penetration are two big challenges for the successful application of nanosystems in tumor therapy. Here, w

    More+
  • ACS Appl. Mater. Interfaces 2017, 9, 3985-3994.

    PLGA-based nanomedicines have enormous potential for targeted cancer therapy. To boost their stability, targetability, and intracellular drug release, here we

    More+
  • Acta Biomaterialia 2017, 50, 396–406.

    Cyclic RGD peptide-functionalized reversibly core-crosslinked biodegradable poly(ethylene glycol)-bpoly(ε-caprolactone) (PEG-PCL) micelles (cRGD-RCCMs) were d

    More+
  • Adv. Mater. 2016, 28, 8234-8239.

    Here, we report on a novel anisamide-functionalized reversibly cross-linked chimeric polymersome (Anis-RCCP) that shows effi cient loading and in vivo lung tum

    More+
  • Chem. Mater. 2016, 28, 8792-8799

    Protein therapeutics offer a most effective treatment for many human diseases, including diabetes, cardiovascular diseases, and malignant tumors. Unlike most c

    More+
  • Biomacromolecules 2016, 17, 3602-3608

    Low tolerability and tumor selectivity restricts many potent anticancer drugs including mertansine from wide clinical use. Here, glutathione-activatable hyalur

    More+
  • J. Control. Release 2016, 239, 149-158

    Pegylated liposomal doxorubicin (Lipo-Dox) is one of the few clinically used cancer nanomedicines. Here we show that tumor-homing, redox-responsive and reversi

    More+